- SEK182.04m
- SEK161.77m
- SEK57.97m
Brief: SenzaGen H1 Sales at SEK 23.6 Million
Brief: Senzagen Expands Distribution Channels
Brief: Senzagen Q1 Net Sales Up At SEK 12.3 Mln
Brief: SenzaGen Wins Order From New Chemicals Customer
Brief: Senzagen H2 EBITDA Loss Narrows To SEK 6.6 Million
Brief: Senzagen Acquires Toxhub For EUR 300,000
Brief: Senzagen Q3 Sales Rise To SEK 9.0 Million
Brief: Senzagen H1 Operating Loss Narrows To SEK 13.7 Million
Brief: SenzaGen Receives Order Worth About SEK 1 Million
Brief: SenzaGen Obtains OECD Approval For Gard®skin
Brief: SenzaGen Wins Order Worth SEK 4.2 Mln
Brief: SenzaGen Receives SEK 1.5 Mln Grant From Research Institute for Fragrance Materials
Brief: SenzaGen Q1 Sales Increases By Over 370% To SEK 9 Million
Brief: SenzaGen Receives Follow-On Order In US
Brief: SenzaGen H2 Operating Loss Widens To SEK 17.5 Mln
Brief: Senzagen Receives Order Worth SEK 1 Mln
Brief: Senzagen Completes Directed Share Issue Of Sek 30 Million
Brief: Senzagen Cancels Target Of Reaching Profitability In 2022
Brief: Senzagen Receives SEK 0.7 Mln Order For GardSkin